107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.

نویسندگان

  • K Bushby
  • F Muntoni
  • J P Bourke
چکیده

Sixteen participants from Austria, France, Germany, Italy, the Netherlands and the UK met to discuss the cardiac implications of the diagnosis of muscular dystrophy and myotonic dystrophy. The group included both myologists and cardiologists from nine different European centers. The aims of the workshop were to agree and report minimum recommendations for the investigation and treatment of cardiac involvement in muscular and myotonic dystrophies, and define areas where further research is needed. During the workshop, all participants contributed to a review and assessment of the published evidence in each area and current practice amongst the group. Consensus statements for the management of dystrophinopathy, myotonic dystrophy, limb-girdle muscular dystrophy, Emery Dreifuss muscular dystrophy, facio-scapulo-humeral muscular dystrophy and congenital muscular dystrophy were produced. The need for further research to extend the evidence-base in certain key areas was also highlighted and outline proposals to resolve these deficiencies put forward. A summary of the cardiac implications of the disorders discussed is presented in Table 1.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

171st ENMC international workshop: Standards of care and management of facioscapulohumeral muscular dystrophy.

An ENMC workshop on standards of care and management of facioscapulohumeral muscular dystrophy (FSHD) patients was held on January 15–17, 2010 in Naarden, The Netherlands. Twenty-four participants from eight countries participated. The primary objective was to develop standards of care in the diagnosis and management of patients with FSHD. Recommendations were formulated based on evidence, when...

متن کامل

170th ENMC International Workshop: bone protection for corticosteroid treated Duchenne muscular dystrophy. 27-29 November 2009, Naarden, The Netherlands.

The first ENMC workshop for bone protection in DMD patients treated with corticosteroids included 18 participants from Europe, USA and Canada. The participants were from diverse backgrounds including Paediatric Neurology, Endocrinology, Metabolic bone disease, Orthopaedics and Medical Physics. The objectives of the workshop were to discuss the problem of vertebral fractures with the following a...

متن کامل

128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands.

Twenty-six participants including parents, scientists, industry representatives and clinicians from Australia, Belgium, England, France, The Netherlands, and USA attended the 128th ENMC workshop on the topic of ‘Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy’. The meeting was held in Naarden, The Netherlands, during the we...

متن کامل

173rd ENMC International Workshop: congenital muscular dystrophy outcome measures 5-7 March 2010, Naarden, The Netherlands.

The 173rd ENMC/TREAT-NMDworkshop on congenital muscular dystrophy (CMD) outcome measures is the 9th CMD workshop, beginning in 1993 with the establishment of a CMD consortium. The workshop brought together 22 clinicians and experts from five countries to advance the implementation of suitable clinical outcome measures and endpoints specific for the CMDs to advance CMD clinical trial readiness. ...

متن کامل

191st ENMC international workshop: recent advances in oculopharyngeal muscular dystrophy research: from bench to bedside 8-10 June 2012, Naarden, The Netherlands.

This workshop hosted a group of 19 clinicians and basic scientist from 5 countries (France, USA, Canada, Denmark and The Netherlands). Recent research developments and possible collaboration in advancing therapies for oculopharyngeal muscular dystrophy (OPMD), a late onset, rare and progressive neurodegeneration disorder were discussed in this meeting. The disease is caused by alanine expansion...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Neuromuscular disorders : NMD

دوره 13 2  شماره 

صفحات  -

تاریخ انتشار 2003